# Atorvastatin as Adjunctive Therapy in COVID-19

> **NCT04380402** · PHASE2 · UNKNOWN · sponsor: **Mount Auburn Hospital** · enrollment: 300 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT04380402
- **Lead sponsor:** Mount Auburn Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-25
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-05-08
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04380402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04380402, "Atorvastatin as Adjunctive Therapy in COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04380402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*